Abstract:Key Points The matrix metalloproteinases (MMPs) comprise a family of zinc-dependent endopeptidases that consist of more than 21 human MMPs and numerous homologues from other species. They can be divided into eight structural classes, three of which are membrane bound. The MMPs are synthesized as inactive zymogens and activated by proteinase cleavage. Their activity is regulated by endogenous inhibitors, including α2-macroglobulin; tissue inhibitors of metalloproteinases (TIMPs); small molecules with TIMP-like domains; and the membrane-bound inhibitor RECK (reversion-inducing cysteine-rich protein with kazal motifs). Direct evidence for a role of MMPs in tumour progression comes from xenograft experiments using cancer cells with decreased and increased expression levels of MMPs or TIMPs, and from carcinogenesis experiments with mice that either lack a specific Mmp or Timp-1 or have organ-specific Mmp or Timp-1 overexpression. MMPs are upregulated in almost every type of human cancer, and their expression is often associated with poor survival. Whereas some of the MMPs (for example, MMP-7) are expressed by the cancer cells, other MMPs (for example, MMP-2 and MMP-9) are synthesized by the tumour stromal cells, including fibroblasts, myofibroblasts, inflammatory cells and endothelial cells. MMPs can promote cancer progression by increasing cancer-cell growth, migration, invasion, metastasis and angiogenesis. MMPs exert these effects by cleaving a diverse group of substrates, which include not only structural components of the extracellular matrix, but also growth-factor-binding proteins, growth-factor precursors, receptor tyrosine kinases, cell-adhesion molecules and other proteinases. Several synthetic MMP inhibitors are undergoing Phase III clinical trials. Although a few encouraging results have been reported, some trials were prematurely terminated due to either lack of benefits or major adverse effects. The clinical trials have so far focused on patients with advanced-stage disease. Based on animal experiments, we would expect, however, that clinical efficacy might be improved either by using MMP inhibitors in the treatment of early disease (in combination with conventional therapy), or as preoperative and postoperative treatment to prevent surgical-induced micrometastatic spread and recurrence of the disease.

Progress on the Role and Mechanism of MT1-MMP in Tumor Metastasis

MMP Enzyme in Tumor Micro-environment: A Promising Target for Nano-medicine Delivery

MT1-MMP as a Key Regulator of Metastasis

Progress in Study of Matrix Metalloproteinases and Tumour Invasion and Metastasis

[Progress of Study on the Roles of Matrix Metalloproteinases in the Pathogenesis of Hematologic Malignancies -- Review].

Matrix Metalloproteinases in Tumorigenesis: an Evolving Paradigm

The Role of Matrix Metalloproteinase in Epithelial-Mesenchymal Transition of Breast Cancer

Endothelial-to-Mesenchymal Transition in the Tumor Microenvironment: Roles of Transforming Growth Factor-β and Matrix Metalloproteins

New functions for the matrix metalloproteinases in cancer progression

Role of Matrix Metalloproteinases (mmps) in Tumor Invasion and Metastasis: Serial Studies on MMPs and TIMPs

The paradoxical role of matrix metalloproteinase-11 in cancer

The Overexpression Membrane Type 1 Matrix Metalloproteinase Is Associated With The Progression And Prognosis In Breast Cancer

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

Decreased Mt1-Mmp in Gastric Cancer Suppressed Cell Migration and Invasion Via Regulating Mmps and Emt

Matrix Metalloproteinases As Novel Biomarker S and Potential Therapeutic Targets in Human Cancer

[Structure, Function and Regulation of MMPs].

Molecular Functions and Significance of the Mta Family in Hormone-Independent Cancer

Recent Advances in Matrix Metalloproteinases-Responsive Nanoprobes for Cancer Diagnosis and Therapy

Matrix Metalloproteinases: New Targets in Cancer Therapy

Research Progress on the Relationship of Metastatic Tumor Antigen 1and Breast Cancer and Its Mechanism

Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu